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Is Mammography Useful in Screening for Local Recurrences 
Patients With TRAM Flap Breast Reconstruction After 
Mastectomy for Multifocal DCIS? 
in 
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Peter W. Possert, MD, Alan M. Yahanda, MD, and Alfred E. Chang, MD 
Background: Skin-sparing mastectomy with immediate transverse rectus abdominis musculo- 
cutaneous (TRAM) flap reconstruction is being used more often for the treatment of breast cancer. 
Mammography is not used routinely to evaluate TRAM flaps in women who have undergone 
mastectomy. We have identified the potential value of its use in selected patients. 
Methods and Results: We report on four women who manifested local recurrences in TRAM 
flaps after initial treatment for ductal carcinoma in situ (DCIS) or DCIS with microinvasion un- 
dergoing skin-sparing mastectomy and immediate reconstruction. All four patients presented with 
extensive, high-grade, multifocal DCIS that precluded breast conservation. Three of four mastec- 
tomy specimens demonstrated tumor close to the surgical margin. Three of the four recurrences were 
detected by physical examination; the remaining local recurrence was documented by screening 
mammography. The recurrences had features suggestive of malignancy on mammography. 
Conclusion: We conclude that all patients undergoing mastectomy and TRAM reconstruction for 
extensive, multifocal DCIS should undergo regular routine marnmography of the reconstructed 
breast. Our experience with this subgroup of patients raises concern about the value of skin-sparing 
mastectomy with immediate reconstruction for therapy. Adjuvant radiation therapy should be rec- 
ommended for those patients with negative but close surgical margins. 
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Breast reconstruction has been demonstrated to be safe 
and effective after surgical removal  of  the breast  in prop- 
erly selected patients with breast cancer. 1-4 Reconstruc- 
tion minimizes the deformity and the psychological  im- 
pact of a mastectomy. 5'6 The advantages of  reconstruc- 
tion with autologous tissue are that it affords a superior 
cosmetic result 7 and is particularly useful in patients who 
have failed breast conservation therapy and have an ir- 
radiated chest wall. Because the timing of  reconstruction 
cannot be expected to compromise the primary opera- 
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tion, alter survival, or interfere with the detection and 
treatment of  tumor recurrence, 1"8 immediate reconstruc- 
tion recently has gained in popularity. The trend toward 
use of  autologous tissue has increased because of  the 
perceived health risks associated with silicone implants. 9 
In addition, skin-sparing mastectomy is being employed 
more often to improve the cosmetic results of  reconstruc- 
tion. m As a result of  the increased use of TRAM flap 
reconstruction, follow-up and management  of  local re- 
currence in the area of  the flap has become a more urgent 
and challenging issue. 
Most  local recurrences appear in the residual skin and 
subcutaneous tissues in the area of  the mastectomy 1~-t3 
and may be attributed to residual breast  tissue, tumor 
seeding at the time of  surgery, or persistence of  tumor in 
the operative field and lymphatics. ~4 With local recur- 
rences occurring anterior to the pectoralis major muscle, 
reconstructions involving the placement of a prosthesis 
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do not significantly interfere with follow-up efforts be- 
cause of their subpectoral location. Myocutaneous flap 
reconstructions, however, occupy the surgical site and 
give rise to the possibility that the flap may mask locally 
recurrent disease because of its normal tissue texture, and 
may lead to a delay in diagnosis. Retrospective studies, 
however, have reported that the detection of locoregional 
recurrences in patients undergoing immediate myocuta- 
neous flap reconstruction after mastectomy was not de- 
layed nor was treatment compromised. 1'15-18 
Issues regarding follow-up and management of these 
patients are still unclear and are further complicated by 
concerns over issues of cost containment in an environ- 
ment of fiscal concern. Local recurrences in recon- 
structed breasts are relatively rare. Because most recur- 
rences occur in the skin and subcutaneous tissues, 11-13 
they usually can be detected on physical examination. 
Therefore, currently accepted follow-up for patients with 
myocutaneous flap reconstruction does not involve the 
use of routine mammography for the detection of local 
recurrence. Moreover, the routine use of mammography 
can lead to the detection of flap abnormalities other than 
recurrent cancer (i.e., fat necrosis) which easily could be 
mistaken for a recurrence, resulting in unnecessary bi- 
opsy procedures.~ 9.,-21 
In this report, we review four cases of local recur- 
rences in patients who underwent skin-sparing mastec- 
tomy with TRAM flap reconstruction. Characteristic 
mammographic changes consistent with malignant find- 
ings are described in three of the four cases. All of the 
patients presented initially with extensive, high-grade 
DCIS and represent a subgroup of patients who have a 
higher risk of local recurrence. We believe that these 
patients should undergo routine mammography of their 
TRAM flaps to identify local recurrences. Moreover, we 
recommend that patients with negative but close (<1 
mm) surgical margins have adjuvant radiation to reduce 
their risk of local recurrence. 
METHODS 
The University of Michigan Cancer Center is a Na- 
tional Cancer Institute-supported comprehensive cancer 
center. All newly diagnosed breast cancer patients (ex- 
cluding stage IV patients) are evaluated in the multidis- 
ciplinary Breast Care Center (BCC), which has been op- 
erational since 1984. The BCC convenes weekly, and 
patients are seen by all the relevant disciplines in one 
clinic setting. A tumor board meets the same day to 
review all new patients, and treatment options are dis- 
cussed. Final recommendations are conveyed to the pa- 
tients the same day they are seen. The BCC evaluates 
approximately 380 new patients each year. 
Recommendations for mastectomy versus breast con- 
servation are made by consensus among members of the 
BCC tumor board. If  mastectomy is required, the option 
of immediate breast reconstruction is reviewed with the 
patient. The type of breast reconstruction is determined 
by the patient in consultation with the plastic surgeon in 
the BCC. 
Skin-sparing mastectomies are performed to obtain 
optimal cosmetic results. Skin-sparing mastectomies in- 
volve removal of all gross breast tissue, including the 
nipple and areola (along with axillary contents if an ax- 
illary dissection is performed). Previous biopsy incisions 
are removed, either in continuity with the nipple-areolar 
complex or separately. To optimize reconstruction, 
maximal preservation of the native skin envelope is 
achieved, and the inframammary fold is kept intact. The 
thickness of the mastectomy skin flaps is equivalent to 
that of mastectomies performed without subsequent re- 
construction. The evaluation of the reconstructed breast 
has not involved routine mammography. 
Four women were identified who had recurrent carci- 
noma in their TRAM flaps following mastectomy for a 
biopsy diagnosis of DCIS. Initial preoperative mammo- 
grams and follow-up mammograms were reviewed. 
Similarly, the microscopic findings of the initial biopsy 
and mastectomy were reviewed, and were compared with 
sections from the recurrent neoplasm. 
CASE REPORTS 
We report four cases of local recurrence of carcinoma 
in patients who had TRAM flap reconstruction following 
total mastectomy for DCIS. Included in these case stud- 
ies are the mammographic findings and the approach 
used in the management of each patient. Table 1 sum- 
marizes these cases. 
Case 1 
Clinical Summary 
This 48-year-old woman underwent a right modified 
radical mastectomy and a left prophylactic total mastec- 
tomy with immediate bilateral TRAM flap reconstruc- 
tion following a biopsy diagnosis of right-sided multifo- 
cal DCIS in August 1994. The prophylactic left mastec- 
tomy was performed at the patient's request. The breast 
reconstruction consisted of a right free TRAM flap and a 
left pedicle TRAM flap. She received no adjuvant 
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TABLE 1. Summary of cases 
Age at Time to Recurrence Treatment of 
Case diagnosis (y) Pathology recurrence palpable recurrences 
1 48 Multifocal DCIS 1 y, 9 m Yes Resection of TRAM, 
chemotherapy and 
radiation therapy 




3 37 Multifocal DCIS with 2 y, 3 m No Resection of TRAM flap, 
focus of microinvasion axillary dissection; 
chemotherapy and 
radiation therapy 
4 42 Multifocal DCIS with 4 y, 8 m Yes Lumpectomy, axillary lymph 
focus of microinvasion node dissection; radiation 
therapy 
therapy. In March 1995, she had bilateral nipple-areolar 
reconstruction. Two months later she developed firmness 
of the reconstructed right breast and some red, nodular 
skin lesions in the area of the scar around her neo-areola. 
A biopsy of the skin lesion revealed invasive mucinous 
carcinoma with dermal angiolymphatic invasion. Mam- 
mogram of the right reconstructed breast revealed a 4 x 
3 cm area of pleomorphic calcifications and soft tissue 
mass that were highly suspicious for malignancy (Fig. 1). 
She underwent a metastatic work-up that included CT 
scans of the chest, abdomen, and pelvis, which proved 
negative. The patient then was treated with resection of 
the right TRAM flap. The excised specimen contained 
invasive carcinoma. She subsequently has been treated 
with chemotherapy and chest wall irradiation and at this 
time is without evidence of recurrent disease. 
Pathologic Findings 
The original breast biopsy contained multifocal DCIS 
of high nuclear grade, and the subsequent mastectomy 
specimen also had multiple foci of DCIS, which ex- 
FIG, I. Craniocaudal mammogram demonstrates a 4 x 3 cm area of 
pleomorphic calcifications with associated soft tissue density in the 
TRAM flap (arrows). Pathology revealed invasive ductal carcinoma. 
tended to within 1 mm of the inked margin of surgical 
excision. The neoplastic ducts had predominant solid and 
comedonecrosis patterns of growth. 
Invasive ductal carcinoma was present in the May 
1995 biopsy and in the subsequent mastectomy. The pre- 
dominant growth pattern was mucinous carcinoma, rep- 
resenting approximately 90% of the neoplasm; in con- 
trast to the usual mucinous carcinoma, however, this 
neoplasm had a high histologic grade and manifested 
invasion of peritumoral and dermal lymphatics. The neo- 
plasm measured 4 cm in greatest dimension, was circum- 
scribed, and was surrounded by foci of high nuclear 




This patient was 47 years old when she underwent a 
left total mastectomy with immediate free TRAM flap 
reconstruction for multifocal DCIS in August 1993. 
Three years later she noted a palpable nodule in the 
superior aspect of her flap, located beneath the preserved 
breast skin flap raised during the initial mastectomy. 
Mammogram of the left TRAM flap revealed a highly 
suspicious, high-density mass 1 cm in diameter, with 
spiculated margins and associated pleomorphic micro- 
calcifications in the area of the palpable abnormality 
(Fig. 2). Fine-needle aspiration cytologic study of the 
nodule was positive for carcinoma. A metastatic work- 
up, including CT scans of the chest and abdomen, was 
negative. Wide excision of the involved area was per- 
formed, with a left axillary lymph node dissection, in 
August 1996. The re-excision lumpectomy contained no 
residual tumor; the axillary lymph node dissection, how- 
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FIG. 2. Mediolateral oblique (A) and craniocaudal (B) mammogram of TRAM flap demonstrates a 1-cm mass with spiculated borders with 
associated microcalcifications highly suspicious for carcinoma (arrow). Invasive ductal carcinoma was found at biopsy. The triangular-shaped soft 
tissue (arrowheads) density noted posteriorly on the mediolateral oblique view (A) represents the rectus musculature. 
ever, revealed that one of twelve lymph nodes contained 
metastatic carcinoma. The patient went on to receive 
adjuvant chemotherapy and radiation therapy and is free 
of recurrence as of this date. 
Pathologic" Findings 
The initial biopsy contained multifocal DCIS of high 
nuclear grade, and the subsequent mastectomy specimen 
also contained extensive mutifocal DCIS of similar 
grade. Although the surgical margins were negative, the 
neoplasm extended to within 1 mm of the surgical mar- 
gin of the mastectomy. 
The August 1996 lumpectomy specimen contained 
multiple foci of high nuclear grade DCIS. Moreover, 
there was an adjacent area of invasive ductal carcinoma 




This patient was 37 years old when she underwent a 
left total mastectomy and a right prophylactic total mas- 
tectomy with immediate bilateral free TRAM flap recon- 
struction for extensive multifocal DCIS of the left breast 
in February 1995. The prophylactic mastectomy was per- 
formed at the patient's request. In May 1995, she under- 
went TRAM flap recontouring and bilateral nipple- 
areolar reconstruction. Two years later, screening mam- 
mography ordered by the pat ient ' s  pr imary  care 
physician revealed two separate areas of suspicious cal- 
cifications in the left reconstructed breast and two small 
masses (<5 mm), of which one had spiculated margins 
and the other was well circumscribed (Fig. 3). These 
lesions were located several centimeters below the skin 
and were not palpable on physical examination. Needle 
localization biopsy of one area of calcification and of the 
spiculated mass revealed separate foci of small invasive 
carcinomas. The patient subsequently underwent resec- 
tion of the involved flap with an axillary dissection. She 
is currently disease-free after adjuvant chemotherapy and 
radiation therapy. 
Pathologic Findings 
The initial biopsy specimen contained multifocal 
DCIS. The neoplasm had a high nuclear grade, and the 
involved cells were of apocrine type and occasionally 
vacuolated. Solid, papillary, cribriform growth patterns, 
as well as comedonecrosis, were seen. The following 
mastectomy also contained multifocal high nuclear grade 
DCIS. In addition, one section contained a focus of stro- 
mal microinvasion (greatest dimension of invasion <I 
mm). The margins of surgical excision were uninvolved 
by neoplasm. 
The 1997 biopsy contained multifocal DCIS of high 
nuclear grade, similar to the neoplasm initially seen. The 
TRAM flap was resected, and and was found to contain 
not only multifocal DCIS but also three foci of invasive 
ductal carcinoma. The largest of these measured 6 mm in 
diameter; the others were 1-mm lesions. All three had a 
high histologic grade. A tumor embolus was noted in a 
lymphatic channel of one axillary tail lymph node; no 
lymph node parenchymal involvement was found in 
seven resected nodes, however. 
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FIG. 3. Close-up mammographic 
views from a patient with multicen- 
tric breast cancer recurrence discov- 
ered solely by screening tramogram. 
(A) A 5-mm irregular marginated 
mass (arrows) with adjacent calcifi- 
cation located in the upper outer 
quadrant of the TRAM. (B) Pleomor- 
phic calcifications with soft tissue 
density noted in the upper inner 
quadrant 9 cm from the lesion shown 
in A. Histology demonstrated inva- 
sive ductal carcinoma with high- 
grade DCIS (black bar = 5 mm). 
Case 4 
Clinical Summary 
This 42-year-old woman underwent a right total mas- 
tectomy with an immediate free TRAM flap reconstruc- 
tion in September 1992. The flap was recontoured and a 
nipple-areola complex was constructed in March 1995. 
One year later invasive ductal carcinoma of the left 
breast was diagnosed, and the patient was treated with a 
modified radical mastectomy and immediate reconstruc- 
tion at another institution. Axillary lymph node dissec- 
tion of that specimen lacked metastatic carcinoma, and 
she received 6 months of postoperative adjuvant chemo- 
therapy followed by tamoxifen. In May 1997, she pre- 
sented with a small nodule in her right TRAM flap, 
which was biopsied and found to be an invasive ductal 
carcinoma with a noninvasive component, extending to 
the surgical margin. A subsequent mammogram of the 
residual TRAM flap did not reveal any other abnormal- 
ity. She was treated with a reexcisional lumpectomy and 
axillary lymph node dissection. The latter revealed re- 
sidual DCIS in the lumpectomy site and absence of 
lymph node metastases. She then was treated with irra- 
diation to the residual TRAM flap. 
Pathologic Findings 
The right breast biopsy performed in July 1994 con- 
tained multifocal, high nuclear grade DCIS with a pre- 
dominant solid growth pattern and with focal stromal 
microinvasion. Extensive DCIS was present in the fight 
mastectomy specimen taken in September 1994. The 
DCIS had a focally papillary growth pattern and in- 
volved ectatic ducts, which extended to within 1 mm of 
a surgical margin of excision. Stromal microinvasion 
also was present in this material. 
The biopsy specimen taken in May 1997 contained a 
1.6-cm circumscribed focus of invasive ductal carcinoma 
of high histologic grade. The biopsy performed the fol- 
lowing month also found multiple loci of DCIS of high 
nuclear grade with focal microinvasion of stroma. 
DISCUSSION 
As a result of the growing popularity and prevalence 
of TRAM flap breast reconstruction, it has become in- 
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creasingly important to define the approach used in fol- 
low-up of patients choosing this alternative. Mammog- 
raphy usually has not been included as part of routine 
follow-up unless an abnormality is detected on physical 
examination. Many researchers consider mammography 
to be of little benefit for oncologic follow-up in recon- 
structed patients. 22 Moreover, breast imaging can lead to 
findings that give false-positive results, including such 
abnormalities as fat necrosis (commonly seen in the early 
postoperative period), oil cysts (which can be calcified), 
and scar t issue. 19-21 Because recurrent carcinoma also 
can occur in the early postoperative period, equivocal 
findings cannot simply be overlooked. Prospective stud- 
ies have not adequately addressed the routine use of 
mammography in the surveillance of myocutaneous 
flaps. Because flap recurrences are not common, the 
cost-benefit ratio of detecting nonpalpable recurrences 
may be low. 
Certain representative mammographic characteristics 
are common to most autologous reconstructions. Myo- 
cutaneous flaps have a relatively uniform fatty appear- 
ance, but lack the usual organization and ductal struc- 
tures of the normal breast. They also lack the typical 
vascular and connective tissue markings seen on normal 
mammograms. The rectus muscle often can be seen an- 
terior to the pectoralis major muscle on the mediolateral 
oblique view. Surgical scars also are seen routinely, al- 
though they vary considerably between patients. Masses 
identified in autologous flaps can represent fat necrosis, 
scars, suture granulomas, chest wall  cysts ,  19-21 and, most 
importantly, recurrent cancer. We have noted that the 
typical radiographic appearance of malignant microcal- 
cifications and masses can be associated with either re- 
current malignancy or new primary cancers in mammo- 
grams of the TRAM flaps ~. 
The cases we have described in this report are striking 
in their similarity of presentation and define a subgroup 
of patients who could benefit from routine postoperative 
screening mammographic studies of the TRAM flap, 
which we have named "tramograms." All four of our 
patients initially presented with extensive multifocal 
DCIS, two of them with microinvasive disease. In all 
four cases, the DCIS was found to be high grade. Three 
of the four patients had tumor close (i.e., <1 mm) to the 
surgical margin. Historically, patients with all forms of 
DCIS fare well with conventional total mastectomy. In a 
review by Delaney et al., 1707 patients summarized from 
9 published reports were treated for DCIS with mastec- 
tomy alone, with a median follow-up of >60 months. 23 
There were ten local recurrences, representing 1.4% of 
the total group, with five of the ten (50%) being invasive 
recurrences. The known risk factors for local recurrence 
after surgical resection (mastectomy as well as lumpec- 
tomy) of DCIS have been reported to be close or in- 
volved margins and the presence of necrosis or high- 
grade tumors. 23-2s The relatively high incidence of in- 
vasive disease (ranging from 54% to 82%) 23'29-31 
associated with local recurrences after surgical therapy 
for DCIS emphasizes the importance of careful follow- 
up in patients with these risk factors. We believe that 
radiographic surveillance of TRAM flaps for patients 
who had mastectomies for multifocal DCIS is mandatory 
and have implemented this screening practice at our in- 
stitution. This screening should be performed for the life- 
time of the patient, because recurrences of low-grade 
DCIS may evolve over a longer interval. 
Our cases bring up concerns regarding the use of skin- 
sparing mastectomy with immediate TRAM flap recon- 
struction in patients with extensive DCIS. This issue has 
not been examined in any large series to date. A retro- 
spective study by Kroll etal. evaluated 104 patients with 
early-stage invasive cancer (excluding DCIS) treated by 
skin-sparing mastectomies and reconstruction, and found 
no increase in local or systemic recurrences compared to 
cases treated by conventional mastectomy. 32 Carlson et 
al. evaluated 327 patients with all stages (stages 0 
through IV) of breast cancer treated with skin-sparing 
mastectomies and did not identify an increased incidence 
of local recurrence in patients with invasive cancers un- 
dergoing this procedure, 33 In their series, no local recur- 
rences were reported in stage 0 patients; the total number 
of patients with DCIS in this group was not described, 
however, nor was there an assessment of those patients 
with focal versus multifocal disease. Obtaining negative 
surgical margins with skin-sparing mastectomies for pa- 
tients with extensive multifocal DCIS may be more prob- 
lematic than it is in patients with focal DCIS. Although 
all four of our cases were found to have negative surgical 
margins, the margins were close in three of them. From 
this experience, we would advocate the use of adjuvant 
radiation therapy when close margins are identified. The 
relative risk of local recurrences in this disease setting in 
patients undergoing skin-sparing mastectomy and imme- 
diate reconstruction must be evaluated in the context of 
a larger data set, which is beyond the scope of this report. 
The management of isolated local recurrences in 
TRAM flaps in patients who presented initially with ex- 
tensive DCIS has not been well documented. All four of 
our patients recurred within a 5-year period with invasive 
ductal carcinomas. None of them presented with meta- 
static stage IV disease. Two were treated with resection 
of the TRAM flap followed by systemic chemotherapy 
and radiation to the chest wall. Two were treated with 
lumpectomy and axillary lymph node dissection. We en- 
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countered no problems associated with flap viability in 
the two patients who required an axillary lymph node 
dissection. One of the two patients had lymph node me- 
tastases and received chemotherapy as well as radiation 
therapy to the residual TRAM flap; the other was node 
negative and received adjuvant radiation only. With the 
very short follow-up period after salvage treatment in our 
patients it is too early to determine the ultimate overall 
survival in these patients; however, all are disease-free at 
the time of this report. 
There is currently no conclusive evidence supporting 
the use of mammography for routine screening of all 
patients with flap reconstructions. However, many ex- 
aminations are being performed by physicians, either in 
response to patient demand or as a result of anecdotal 
experience. Other anecdotal reports have described the 
detection by screening mammography of nonpalpable, 
locally recurrent cancer in reconstructed breasts post- 
mastectomy. 34'3s Whether recurrences in TRAM flaps 
detected earlier with mammography can be treated more 
successfully than those detected by routine physical ex- 
amination is unknown and would probably be difficult to 
determine, based on the infrequent occurrence of such 
recurrences. Sparing lhe TRAM flap with early detection 
of a local recurrence may represent a secondary benefit 
of routine tramography. We have instituted a program to 
screen all of our breast cancer patients who have TRAM 
flaps to determine prospectively the value of this ap- 
proach and to characterize the natural history of radio- 
logic findings in these patients. 
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